Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Is the Options Market Predicting a Spike in Athira Pharma (ATHA) Stock?
02:47pm, Monday, 13'th Dec 2021 Zacks Investment Research
Investors need to pay close attention to Athira Pharma (ATHA) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Athira Pharma (ATHA) Stock?
11:30am, Monday, 13'th Dec 2021
Investors need to pay close attention to Athira Pharma (ATHA) stock based on the movements in the options market lately.
Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Up 29.9% in November
12:26pm, Saturday, 04'th Dec 2021 Transcript Daily
Athira Pharma, Inc. (NASDAQ:ATHA) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,520,000 shares, an increase of 29.9% from the October 31st total of 1,170,000 shares. Currently, 4.4% of the shares of the company are short sold. Based on an average daily []
California State Teachers Retirement System Has $456,000 Stock Holdings in Athira Pharma, Inc. (NASDAQ:ATHA)
10:20am, Wednesday, 01'st Dec 2021 Dakota Financial News
California State Teachers Retirement System boosted its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA) by 112.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,492 shares of the companys stock after buying an additional 23,559 shares during the []
Walleye Capital LLC Invests $475,000 in Athira Pharma, Inc. (NASDAQ:ATHA)
01:02pm, Monday, 15'th Nov 2021 Dakota Financial News
Walleye Capital LLC purchased a new position in shares of Athira Pharma, Inc. (NASDAQ:ATHA) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 46,421 shares of the companys stock, valued at approximately $475,000. Walleye Capital LLC owned 0.12% of Athira Pharma at the end of []
Athira Pharma to Present at Upcoming Investor Conferences
07:00am, Monday, 08'th Nov 2021
-Stifel 2021 Virtual Healthcare Conference- - Jefferies 2021 London Healthcare Conference-
Why Shares of Athira Pharma Are Climbing Today
11:45am, Friday, 22'nd Oct 2021
The clinical trial for its Alzheimer's drug is one step closer to completion.
Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigation
05:38pm, Thursday, 21'st Oct 2021
Leen Kawas has formally resigned as CEO of Athira Pharma and is stepping off the board after an investigation found the biotech executive altered images in scientific papers she authored.
Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer's Disease (CTAD) Conference
08:05am, Wednesday, 29'th Sep 2021
BOTHELL, Wash., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health
Athira Pharma, Inc. (ATHA) Dips More Than Broader Markets: What You Should Know
07:04pm, Friday, 17'th Sep 2021
Athira Pharma, Inc. (ATHA) closed at $10.13 in the latest trading session, marking a -1.65% move from the prior day.
Athira Shareholder Alert
06:36pm, Friday, 27'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Last Day for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC
11:00am, Tuesday, 24'th Aug 2021
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athira Pharma, Inc. ("Athira " or "the Company
Los Angeles, California--(Newsfile Corp. - August 24, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
San Francisco, California--(Newsfile Corp. - August 24, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Athira Pharma, Inc. Investors – ATHA
02:43pm, Monday, 23'rd Aug 2021
RANDOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuits have been filed against Athira Pharma, Inc. (NASDAQ: ATHA
